Literature DB >> 22120825

The effect of miR-7 on behavior and global protein expression in glioma cell lines.

Ze Jun Lu1, Sheng Yong Liu, Yu Qin Yao, Yong Jun Zhou, Shuang Zhang, Lei Dai, Hong Wei Tian, Yan Zhou, Hong Xin Deng, Jin Liang Yang, Feng Luo.   

Abstract

Malignant glioma is a common cancer of the nervous system. Despite recent research efforts in cancer therapy, the prognosis of patients with malignant glioma has remained dismal. MicroRNAs are noncoding RNAs that inhibit the expression of their targets in a sequence-specific manner, and a few have been shown to act as oncogenes or tumor suppressors. Here, we aimed at exploring the precise biological role of microRNA-7 (miR-7) and the global protein changes in glioma cell lines transiently transfected with miR-7. Transfection of miR-7 into glioma cell lines causes inhibition of cell migration and invasion and suppression of tumorigenesis. Moreover, ectopic expression of miR-7 inhibits lung metastases of glioma in vivo. Among 65 protein spots with differential expression separated by 2-DE, 37 proteins were successfully identified by MS/MS analysis. Of those, the 25 downregulated proteins, which include 14-3-3ζ, eukaryotic translation initiation factor 5A (EIF5A), and annexin A4, may be downstream targets of miR-7, a finding that could elucidate some aspects of the behavior of glioma cells at the protein level. In conclusion, the absence of miR-7 function could cause downstream molecules to switch on or off, resulting in glioma development, invasion, and metastases. MiR-7-based gene treatment may be a novel anti-invasion therapeutic strategy for malignant glioma.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22120825     DOI: 10.1002/elps.201100230

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  14 in total

1.  MiR-302c-3p suppresses invasion and proliferation of glioma cells via down-regulating metadherin (MTDH) expression.

Authors:  Yonghong Wang; Yujun Wei; Haibo Tong; Laizhao Chen; Yimin Fan; Yuchen Ji; Wenqing Jia; Dongkang Liu; Guihuai Wang
Journal:  Cancer Biol Ther       Date:  2015-07-15       Impact factor: 4.742

Review 2.  Current progress for the use of miRNAs in glioblastoma treatment.

Authors:  Amanda Tivnan; Kerrie Leanne McDonald
Journal:  Mol Neurobiol       Date:  2013-04-28       Impact factor: 5.590

3.  The prognostic significance of annexin A family in glioblastoma.

Authors:  Hankun Xu; Xiaoqian Wu; Yingfei Dou; Wei Zheng
Journal:  Ir J Med Sci       Date:  2021-08-16       Impact factor: 2.089

4.  Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.

Authors:  Wenwei Chen; Lihong Chen; Zhixiong Cai; Dong Liang; Bixing Zhao; Yongyi Zeng; Xiaolong Liu; Jingfeng Liu
Journal:  Tumour Biol       Date:  2016-01-16

Review 5.  A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion.

Authors:  Heidi G Møller; Andreas P Rasmussen; Hjalte H Andersen; Kasper B Johnsen; Michael Henriksen; Meg Duroux
Journal:  Mol Neurobiol       Date:  2012-10-02       Impact factor: 5.590

6.  MicroRNA in Human Glioma.

Authors:  Mengfeng Li; Jun Li; Lei Liu; Wei Li; Yi Yang; Jie Yuan
Journal:  Cancers (Basel)       Date:  2013-10-23       Impact factor: 6.639

7.  Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.

Authors:  Michael Preukschas; Christian Hagel; Alexander Schulte; Kristoffer Weber; Katrin Lamszus; Henning Sievert; Nora Pällmann; Carsten Bokemeyer; Joachim Hauber; Melanie Braig; Stefan Balabanov
Journal:  PLoS One       Date:  2012-08-21       Impact factor: 3.240

8.  Altered expression of 14-3-3ζ protein in spinal cords of rat fetuses with spina bifida aperta.

Authors:  Li-na Wu; Xiao-wei Wei; Yang Fan; Jia-ning Miao; Li-li Wang; Yi Zhang; Di Wu; Zheng-wei Yuan
Journal:  PLoS One       Date:  2013-08-06       Impact factor: 3.240

9.  Bioinformatic analysis of the membrane cofactor protein CD46 and microRNA expression in hepatocellular carcinoma.

Authors:  Zejun Lu; Chuanfu Zhang; Jiajun Cui; Qi Song; Ligui Wang; Jingbo Kang; Peng Li; Xiaofeng Hu; Hongbin Song; Jinliang Yang; Yansong Sun
Journal:  Oncol Rep       Date:  2013-11-28       Impact factor: 3.906

10.  Metabolism-related enzyme alterations identified by proteomic analysis in human renal cell carcinoma.

Authors:  Zejun Lu; Yuqin Yao; Qi Song; Jinliang Yang; Xiangfei Zhao; Ping Yang; Jingbo Kang
Journal:  Onco Targets Ther       Date:  2016-03-09       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.